• Are Generic Health State Utility Instruments Sufficiently Sensitive To Capture Changes In Health-Related Quality of Life In Patients With Visual Disorders?

    Oct 1, 2017, 00:00

  • Evaluación De Pertinencia Científica Y Análisis De Costo-Efectividad En Las Intervenciones De Salud

    Oct 1, 2017, 00:00

  • Societal Preferences For Funding Orphan Drugs In The UK- An Application Of Value Based Pricing Using Discrete Choice Experiment Methods

    Oct 1, 2017, 00:00

  • Quantitative Assessment of Ophthalmologist Prescribing Patterns for Severe Vernal Keratoconjunctivitis (VKC) To Inform Payer Decision Making In The Eu

    Oct 1, 2017, 00:00

  • Medication Use During Pregnancy in the Netherlands- A Population-Based Study

    Oct 1, 2017, 00:00

  • Validação Do Método Simple Exponential Smoothing with Additive Para Realização De Previsões De Gasto Com Importação De Produtos Farmacêuticos

    Oct 1, 2017, 00:00

  • Pharmacology for Peripheral Arterial Disease in the Netherlands; Patient Journey and Platelet Aggregation Inhibitor Prescription

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of The Use Of Daclatasvir + Asunaprevir in The Treatment of Patients with Chronic Hepatitis C in Peru

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization in Patients with Moderate to Severe Ulcerative Colitis- A Brazilian Real World Study

    Oct 1, 2017, 00:00

  • Evaluation Of Measles Vaccination Coverage In Austria

    Oct 1, 2017, 00:00

  • Using Outcome Data to Inform Healthcare Professional – Patient Discussion- A Database of Treatment Effects

    Oct 1, 2017, 00:00

  • Estimating the Comparative Accuracy of Diagnostic Tests- AN Example using Typhoid Fever

    Oct 1, 2017, 00:00

  • Fatores Associados Aos Gastos com Imagenologia No Sistema Unico De Saude Brasileiro

    Oct 1, 2017, 00:00

  • Cost Impact of Protocol Compliance for Cancer Treatment Plans in The Private Healthcare Environment

    Oct 1, 2017, 00:00

  • real-World Data (RWD) On The Attainment Of Composite Quality Measures (Cqm) In A Brazilian Population With Self-Reported Type-2 Diabetes Mellitus (T2DM)

    Oct 1, 2017, 00:00

  • Yellow Fever’s Next Move- The Rising Fear

    Oct 1, 2017, 00:00

  • Differences in Distributional Properties and Responsiveness Between A Generic (EQ-5d) and Disease-Specific (ASUI) Utility Instrument in Patients with Severe Eosinophilic Asthma

    Oct 1, 2017, 00:00

  • Will 2017 Updates To The Highly Specialised Technologies Programme Benefit or Harm Vulnerable Patients?

    Oct 1, 2017, 00:00

  • Work Accident Costs. Security, Healthcare and Human Resources Departments Links

    Oct 1, 2017, 00:00

  • Survival Outcomes Predicted By A Discrete Event Simulation Model For Renal Cell Carcinoma For Use In A Cost Effectiveness Analysis- A Comparison With A Traditional Partitioned Survival Model

    Oct 1, 2017, 00:00

  • Incidence Of Surgery For Inflammatory Bowel Disease Within 12 Months Of Initiation Of Vedolizumab Or Infliximab

    Oct 1, 2017, 00:00

  • Evaluating Cost of Regimens in Hepatitis C Treatment from Healthcare Payer Vietnam’s Perspective

    Oct 1, 2017, 00:00

  • Do Changing Attitudes To Death Have Implications For National Tariffs For Health States? Results From An Examination Of Attitudes To Euthanasia In The Republic Of Ireland

    Oct 1, 2017, 00:00

  • The Success Of EU Omp Legislation- An Empirical Analysis

    Oct 1, 2017, 00:00

  • Acute Lymphoblastic Leukaemia’s Burden Of Disease In Portugal

    Oct 1, 2017, 00:00

  • Development of a New Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis- Nash-Check

    Oct 1, 2017, 00:00

  • Medical Cost Evaluation of Apixaban Versus Warfarin In Patients With Nonvalvular Atrial Fibrillation- Japanese Claims Database Analysis

    Oct 1, 2017, 00:00

  • Persistence in Hypertension Therapy in Patients with and Without Depression in Germany

    Oct 1, 2017, 00:00

  • Traditional and Complementary Medicine in Pregnancy and Postpartum- Reasons and Perceptions

    Oct 1, 2017, 00:00

  • Comparing Efficacy of Guselkumab Versus Ustekinumab in Moderate to Severe Psoriasis Patients - An Adjusted Comparison Based on Voyage 12 and Navigate Trials

    Oct 1, 2017, 00:00

  • Profile of Brazilian Inpatients With Mental Disorders Covered By Private Health Care In The State of Ceara- A Real World Data Analysis

    Oct 1, 2017, 00:00

  • Burden of Arthritic Manifestations on Psoriatic Patients - Sub-Analysis of Pessoa, A Patient Reported Outcomes Study In Portugal

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apixaban For Stroke Prevention In Atrial Fibrillation- An Kazakhstan Perspective

    Oct 1, 2017, 00:00

  • The Impact Of Long Acting Injectable Antipsychotics On The Health And Economic Outcomes Of Schizophrenia Patients In Brazil

    Oct 1, 2017, 00:00

  • Costs Analysis Of Novel Flash Glucose Monitoring Technology In Adults With Type 2 Diabetes Mellitus (T2DM) Under Insulin Treatment In Spain

    Oct 1, 2017, 00:00

  • Generic Reimbursed Market Shares In Greece From 2012-2016. A Study Based On Age Group Preferences

    Oct 1, 2017, 00:00

  • Changes In Treatment Patterns Of Tyrosine Kinase Inhibitors Among Non-Small Cell Lung Cancer Patients Under The National Health Insurance In Taiwan

    Oct 1, 2017, 00:00

  • Complementary and Alternative Medicine in the Management of Pain- A South African Community Survey

    Oct 1, 2017, 00:00

  • School Communities’ Participation In Health Promotion Process In Lithuania

    Oct 1, 2017, 00:00

  • Conditions And Contextual Factors That Influence The Utility And Application Of Patient Preference Studies- A Study Combining Literature And Focus Groups

    Oct 1, 2017, 00:00

  • Comparison of Weighting Methods Used During The Construction of Multiple-Criteria Decision Analysis Tool for Repeated Use In Lower Income Countries

    Oct 1, 2017, 00:00

  • Adult Risk Factors of Noncommunicable Disease Outcomes

    Oct 1, 2017, 00:00

  • HCV Network Of Sicilian Region- A Best Practice To Monitor Cost And Consequence Of Treatments

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of ENTEREX® HPT, A Specialized Nutrition Supplement, for Patients with Liver Disease in Mexico

    Oct 1, 2017, 00:00

  • Practical considerations for a dialysis provision model of care for end-stage renal disease (esrd). Benchmark of international experiences, opportunities for the mexican social security institute (imss)

    Oct 1, 2017, 00:00

  • The Unknown Burden Of Celiac Disease In The US And Globally

    Oct 1, 2017, 00:00

  • Healthcare Resource Utilization in Patients with Moderate to Severe Crohn’s Disease- A Brazilian Real World Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Extracorporeal Shock Wave Lithotripsy Versus Retrograde Intrarenal Surgery In The Management of Small Moderated-Sized Renal Stones

    Oct 1, 2017, 00:00

  • Evaluating the Impact of PCSK9 Inhibitors on Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Secukinumab Shows Higher Symptomatic improvement Versus Infliximab in Psoriatic Arthritis- Comparative Effectiveness Up To 1 Year Assessed by Matching-Adjusted Indirect Comparisons

    Oct 1, 2017, 00:00

  • Disinvestment of Health Technologies by the National Commission for Technology Incorporation from 2012-2016

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Inpatient Rehabilitation Compared To Home Discharge Following Longer Stay In General Or Neurological Ward, After Admission For The First Ever Stroke In Greece

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Second-Line Pharmacological Treatments of Acromegaly In Spain

    Oct 1, 2017, 00:00

  • Impact Of Lifestyle Education And Pharmacist Intervention Of Drug-Related Problems On Elders At High Risk Of Having Dementia

    Oct 1, 2017, 00:00

  • Caregiver Burden In Daily Human Growth Hormone Injections For Children

    Oct 1, 2017, 00:00

  • Revisiting Indirect Health Preference Elicitation As A Base Case

    Oct 1, 2017, 00:00

  • Evaluación Económica De Medicamentos Para El Tratamiento De Síndrome Metabólico Desde La Perspectiva De Un Sistema De Salud Privado En Mexico

    Oct 1, 2017, 00:00

  • Public Hospital Supply Chain- Current View And Critical Issues In Italy

    Oct 1, 2017, 00:00

  • Comparing Cost-Effectiveness of Strategies for Antenatal Hiv Testing- VCT and Routine Testing in Urban Nigeria

    Oct 1, 2017, 00:00

  • Drug Cost Containment And Negotiation Power

    Oct 1, 2017, 00:00

  • Atopic Dermatitis In Adults- Impact on Sexuality

    Oct 1, 2017, 00:00

  • What Matters to Spanish Patients and Physicians when Facing Decisions for Gep-Net? An Exploration Using a Reflective Multicriteria Shared-Decisionmaking Framework

    Oct 1, 2017, 00:00

  • Examination of Effectiveness of Group Physiotherapy Using Dash Questionnaire After Distal Radial Fracture

    Oct 1, 2017, 00:00

  • Clinical Efficacy And Safety Of Licensed Drugs And Potential New Therapies For Non-Metastatic Castration-Resistant Prostate Cancer- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Caracterización Clínica Y Económica De Hospitalización Por Varicela En Niños En La Región Metropolitana Y Región De Valparaíso, Chile

    Oct 1, 2017, 00:00

  • Waiting List Mortality Impact in Hcv Cirrhotic Patients

    Oct 1, 2017, 00:00

  • Flaring Among Atopic Dermatitis Patients – The Perception of Flaring Burden Between Physicians and Patients

    Oct 1, 2017, 00:00

  • Efficient Secondary Use of Representative Social and Health Care Data In Finland- Isaacus Data Lake, Analytics and Knowledge Management Pre-Production Project

    Oct 1, 2017, 00:00

  • The Economic And Humanistic Burden of Patients on Treatment for Neovascular Age-Related Macular Degeneration

    Oct 1, 2017, 00:00

  • Relación Entre Los Factores Sociodemográfico, Económicos, Condición Clínica Y La Calidad De Vida Relacionada A Salud- Explorando La Eq-5d Y Eq-Vas En Chile

    Oct 1, 2017, 00:00

  • Health Care Cost In Patients Undergoing Electrical Cardioversion- An Analysis From The Edoxaban Versus Warfarin In Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Study

    Oct 1, 2017, 00:00

  • Pipeline Assessment Of Βeta-Secretase Inhibitors For Alzheimer’s Disease- Hopes Or Gloom For A Trillion Dollar Market

    Oct 1, 2017, 00:00

  • Comparison of Health Technology Assessments in Rheumatology from 2012 To 2016

    Oct 1, 2017, 00:00

  • Costs Associated with Disease Progression in Advanced Melanoma - A Claims Analysis Using A Novel Staging Algorithm

    Oct 1, 2017, 00:00

  • Assessment of Lipid-Lowering Therapy Prescribing Among Patients with Type 2 Diabetes Mellitus in Malaysian Primary Care Settings

    Oct 1, 2017, 00:00

  • Flexible-Dose Depot Buprenorphine Injection for Opioid Substitution Treatment In Heroin-Addicted Adults- A Swedish Pharmacoeconomic Perspective

    Oct 1, 2017, 00:00

  • Substitution Therapy With Flexible-Dose Depot Buprenorphine Injection To Treat Opioid Use Disorder In The United Kingdom- A Pharmacoeconomic Assessment

    Oct 1, 2017, 00:00

  • Dosing Patterns Associated With Deflazacort Use In Duchenne Muscular Dystrophy (DMD)- Observations From Deflazacort Early Access Program (EAP) In The U.S

    Oct 1, 2017, 00:00

  • Case Fatality Rate of Enteric Fever- A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Chronic Non-Communicable Diseases (NCDS) and Body Mass Index (BMI) of Beneficiaries and Non-Beneficiaries of Private Health Plans In Brazil

    Oct 1, 2017, 00:00

  • Patients’ Experiences Living With Chronic Hepatitis B Infection- A Multinational Qualitative Study

    Oct 1, 2017, 00:00

  • Risk Factors And Diagnosis Of Nontuberculous Mycobacterial Lung Disease (NTMLD) In Incident Cohorts Of Bronchiectasis (BE) And Chronic Obstructive Pulmonary Disease (COPD) In A National US Managed Care Insurance Plan

    Oct 1, 2017, 00:00

  • Economic Impact Of Nurse Sensitive Outcomes In Irish Hospitals

    Oct 1, 2017, 00:00

  • Playing in the Same Pond - The Impact of Brexit on Clinical Trials and Access

    Oct 1, 2017, 00:00

  • Using Real-World Data (RWD) in Health Technology Assessment (HTA) Practi A Comparative Study of 5 HTA Agencies

    Oct 1, 2017, 00:00

  • Ageing of the Working Population and Disability Insuran An Economic and Demographic Analysis on the Disability Benefit in Italy

    Oct 1, 2017, 00:00

  • Understanding Hta and Patient Engagement- Effect of Integrating Experiential and Knowledge Learning Modules

    Oct 1, 2017, 00:00

  • Custos Diretos De Eventos Adversos Identificados Em Um Hospital De Grande Porte No Brasil

    Oct 1, 2017, 00:00

  • Análise De Custo-Comparação Entre Os Programas Para Pessoas Com Deficiência Intelectual E Do Desenvolvimento Cognitivo- Suporte Individualizado E Instituições De Saúde Mental

    Oct 1, 2017, 00:00

  • Parental Satisfaction With Medications Therapy And Parenting Stress Among Parents With Asthmatic Children

    Oct 1, 2017, 00:00

  • Assessing Preferences in Discrete Choice Experiments (DCES)- Effects of the Applied Design on the Study Results

    Oct 1, 2017, 00:00

  • Evaluation Framework for Digital Medicines in Europe

    Oct 1, 2017, 00:00

  • Health State Utilities In Patients with Relapsing Remitting Multiple Sclerosis Treated with Cladribine Tablets

    Oct 1, 2017, 00:00

  • Representativeness of Routinely Collected Patient-Reported Outcome Data in Coronary Revascularization Patients?

    Oct 1, 2017, 00:00

  • Development of Pharmacoeconomic Guidelines In Ukraine- Methodological Issues And Policy Implications

    Oct 1, 2017, 00:00

  • Using Regression Models To Accommodate Heterogeneity And Address Cohort Imbalance In Parametric Survival Models For Use In HTA

    Oct 1, 2017, 00:00

  • Cost Utility Analysis of Single Fraction Versus Multiple Fraction Radiotherapy in Patients with Painful Bone Metastases; an Iranian Patient's Perspective Study

    Oct 1, 2017, 00:00

  • Retrospective Survey for Hepatitis B Virus Reactivation During Immunosuppressive Therapies For Rheumatoid Arthritis Using Administrative Data

    Oct 1, 2017, 00:00

  • An Assessment Of Correlation Between Mortality And Distance From Patient’s Residence To Interventional Center In Percutaneous Coronary Intervention In Brazil

    Oct 1, 2017, 00:00

  • Efficacy and Safety of Topical Dapsone Gel 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Type

    Oct 1, 2017, 00:00

  • An Economic Evaluation Model for Follicular Lymphoma (FL)- Predicting Treatment Cost, Life Expectancy and Quality-Adjusted Life Year of Different Scenarios Using UK Population Based Observational Data

    Oct 1, 2017, 00:00

  • Payer Management Of High-Cost Brand-On-Brand Combination Therapies In Oncology

    Oct 1, 2017, 00:00

  • European Initiatives To Enhance Biosimilar Adoption

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of ACEI And ARBS II Drugs In Patients With Arterial Hypertension

    Oct 1, 2017, 00:00

  • What is The Economic Impact of CCP Test Misclassification in Rheumatoid Arthritis Diagnosis? A Benchmarking Simulation Study in Spain

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Flash Glucose Monitoring System Based On Real-World Usage For Type 2 Diabetes (T2DM) Patients Using Intensive Insulin- A Swedish Perspective

    Oct 1, 2017, 00:00

  • The Impact of The Learning Curve on Costs and Effects of Novel Medical Devices. Evidence From Registry Data

    Oct 1, 2017, 00:00

  • The Effects Of The Economic Crisis On Health Status And Health Inequalities In Greece

    Oct 1, 2017, 00:00

  • Impact Of Health Policies On Catastrophic Health Expenditures In Turkey

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life (HRQOL) and Disease Symptoms in Patients with Unresectable Hepatocellular Carcinoma (HCC) Treated with Lenvatinib (LEN) or Sorafenib (SOR)

    Oct 1, 2017, 00:00

  • Clinical Outcomes of Theophylline use as Add-On Therapy In Patients with Chronic Obstructive Pulmonary Disease- A Propensity Score Matching Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of A Pharmaceutical Care Program For Systemic Arterial Hypertension Care Into Brazilian Public Heath System

    Oct 1, 2017, 00:00

  • Economic Evaluation of Egfr Control In Patients With Chronic Kidney Disease In Japan

    Oct 1, 2017, 00:00

  • Cost-Minimization of Somatropin for GH Deficiency and Turner Syndrome Treatment from SUS Perspective

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis Of Darunavir-Based Regimens For Treatment-Experienced Patients With Multidrug-Resistant HIV-1 Infection In Thailand

    Oct 1, 2017, 00:00

  • Conitec Reimbursement Decisions- Is There A Cost-Utility Decision Threshold?

    Oct 1, 2017, 00:00

  • Burden of Genital Warts in Argentina. Preliminary Report of an Observational Study

    Oct 1, 2017, 00:00

  • Economic Burden of Heart Failure In Asian Countries

    Oct 1, 2017, 00:00

  • Assessment of The Efficacy of The Two-Year Treatment With Omalizumab, According to The Pediatric Registry of The Children with Severe Persistent Uncontrolled Asthma

    Oct 1, 2017, 00:00

  • Comparison Of Standard Parametric Survival Methods Versus More Flexible Approaches

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Adopting Evolocumab In The Brazilian Private Healthcare System For Patients With Uncontrolled LDL-C And High Cardiovascular Risk

    Oct 1, 2017, 00:00

  • A Budget-Impact Analysis (BIA) Of Immunizing Adults With Copd With The 13-Valent Vaccine (PCV13) Against Community- Acquired Pneumonia And Pneumococcal Disease

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Vaccines- What Are The Methodological Issues?

    Oct 1, 2017, 00:00

  • Guideline Adherence In Docetaxel Treatment Of Castration Resistant Prostate Cancer (CRPC) Patients In A Real-World Population- The Castration Resistant Prostate Cancer Registry (CAPRI) In The Netherlands

    Oct 1, 2017, 00:00

  • Decreasing Acef Score In Patients Underwent Myocardial Infarction Affects Patients’ Life Years Gained

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Landiolol, An Ultra-Short-Acting Beta-Blocker, For Prevention of Postoperative Atrial Fibrillation In Germany

    Oct 1, 2017, 00:00

  • Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign ...

    Oct 1, 2017, 00:00

  • Real World Data In France – State of The Art

    Oct 1, 2017, 00:00

  • Efficacy and Cost-Effectiveness of Second-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer

    Oct 1, 2017, 00:00

  • The Development of Drug Price Index for Each Health Care Sector in Taiwan

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Mechanical Thrombectomy Compared with Standard Treatment in Patients with Acute Ischaemic Stroke

    Oct 1, 2017, 00:00

  • Price-Dose Relationship- The Case of Oral Oncology Drugs in Eu5

    Oct 1, 2017, 00:00

  • Herpes Zoster Related Healthcare Burden And Costs In Both Immunocompromised (IC) And Ic-Free Populations In The United Kingdom

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact In Hospitalization Persistent Severe Asthma Patients

    Oct 1, 2017, 00:00

  • Evaluation Of Branding Impact On Iranian Pharmaceutical Market- A Qualitative Study

    Oct 1, 2017, 00:00

  • Secukinumab Significantly Reduces Work Impairment and Indirect Costs Compared To Ustekinumab and Etanercept In The United Kingdom

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Brentuximab Vedotin As Consolidation Treatment After Autologous Stem-Cell Transplantation in Patients With Hodgkin Lymphoma and Increased Risk of Relapse

    Oct 1, 2017, 00:00

  • International HTA Experience With Targeted Therapy Approvals For Lung Cancer

    Oct 1, 2017, 00:00

  • Imagem Corporal EM Mulheres Submetidas Ao Tratamento Do Câncer De Mama

    Oct 1, 2017, 00:00

  • Acne Vulgaris- Prevalence, Clinical forms and its Management in Pharmacy Students from Bahawalpur, Pakistan

    Oct 1, 2017, 00:00

  • Appropriate Ankylosing Spondylitis (AS) Treatment is Delayed For Years- Results From a Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Effectiveness of Telemonitoring Interventions for Chronic Obstructive Pulmonary Disease

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Plurogel® - A New Micelle-Matrix-Based Dressing With 1% Silver Sulphadiazine – In The Management of Non-Healing Wounds

    Oct 1, 2017, 00:00

  • The Relationship Between Severity of Chronic Kidney Disease and Health Related Quality of Life Among a Nationally Representative Sample of Community Dwelling Adults in England

    Oct 1, 2017, 00:00

  • Costo Utilidad De Los Bloqueadores HER2 Contra El Cáncer De Mama Metastásico En Mujeres Peruanas

    Oct 1, 2017, 00:00

  • Avaliação Da Qualidade De Vida EM Crianças E Adolescentes COM ASMA

    Oct 1, 2017, 00:00

  • Bringing Molecular Diagnostic Tests Into Clinical Practi Mapping The Evidence Pathway

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Treprostinil To Treatment of Patients With Pulmonary Arterial Hypertension Nyha Class Iv Without Response To Pharmacological Therapies In Mexico

    Oct 1, 2017, 00:00

  • Patient-Reported Outcomes from Phase 3 Baricitinib Ra-Beam Study- Latin American Subgroup Analysis

    Oct 1, 2017, 00:00

  • Multipathogen Detection Methods For l. Monocytogenes In Food Sample- A Systematic Review

    Oct 1, 2017, 00:00

  • Early HTA Advice In European Countries- Scope And Associated Costs

    Oct 1, 2017, 00:00

  • Occurrence or Remission of Antidiabetic Treatment Six Years after Bariatric Surgery- A Nationwide Matched Cohort Study

    Oct 1, 2017, 00:00

  • Deciding On Universal Rotavirus Vaccination In The Netherlands - Again

    Oct 1, 2017, 00:00

  • Can We Use Demqol-Proxy With Confidence? Robust Solutions To Practical Problems

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Daclatasvir/Sofosbuvir (DCV/SOF) For The Treatment Of HCV Patients Who Failed After First Line Treatment With Second Generation Of Daa In Italy

    Oct 1, 2017, 00:00

  • Cost Comparison of Treatment Choices for Advanced Non-Small Cell Lung Cancer- An Observational Study

    Oct 1, 2017, 00:00

  • Use Of The Ims Core Diabetes Model (CDM) In A Long-Term Projected Health Economic Comparison Of CSII And MDI Treatments Of Type 1 Diabetes (T1D) In A Newly-Diagnosed Population Of Paediatric Patients

    Oct 1, 2017, 00:00

  • Avaliação Dos Custos Por Tipo De Internação Em Uma Operadora De Planos De Saúde- Uma Análise De Dados Do Mundo Real

    Oct 1, 2017, 00:00

  • Cost Illness Of Rsv Infection In Colombia

    Oct 1, 2017, 00:00

  • Health State Utilities in Individuals with Goiter, Hypothyroidism, Hyperthyroidism and Graves’ Disease as an Example for Thyroid Disorders – A Systematic Review

    Oct 1, 2017, 00:00

  • Integrated Care Models In Germany – Potential Market Access Route For Medical Devices?

    Oct 1, 2017, 00:00

  • The Impact of The Rads Assessment- Can Fewer Injections With Intravitreal Aflibercept Translate To Lower Overall Treatment Burden and Costs In Wamd When Compared With Intravitreal Ranibizumab?

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Supra-Ciliary Microstent Device Utilization In Primary open Angle Glaucoma Patients In A Spanish Hospital Outpatient Setting

    Oct 1, 2017, 00:00

  • Matching Adjusted Indirect Comparison Of Sunitinib And Everolimus For The Treatment Of Pancreatic Neuroendocrine Tumours (PNETS)

    Oct 1, 2017, 00:00

  • Prevalence of Obstructive Sleep Apnea in German In-Hospital Patients

    Oct 1, 2017, 00:00

  • Calidad De Vida En Salud En Pacientes Amputados De Extremidad Inferior Con Protesis De Un Hospital De Especilidad Público Chileno

    Oct 1, 2017, 00:00

  • Efficacy Of Antioxidant Supplements On Prevention And Amelioration Of Diabetes-Induced Nephropathy- A Systematic Review And Meta-Analysis Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Comparison of Methods to Measure Patient Adherence and Persistence with Pharmacological Therapy- A Systematic Review

    Oct 1, 2017, 00:00

  • Too Broad To Be Sensitive? Exploring The Responsiveness Of The Icecap-O Capability Wellbeing Measure Compared To The EQ-5D-3L To The Change Of Clinical And Qol Aspects In People With Parkinson’s

    Oct 1, 2017, 00:00

  • Influence of Computer Games on the Health and Quality of Students Academic Performance

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact At Health Care Perception At Patients Diagnosed With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • Budget Impact Of Newly Approved Drugs By The Sicilian Drug Formulary Committee- An Introductive Analysis

    Oct 1, 2017, 00:00

  • Importance Of Tendering After Patent Expiry In Germany

    Oct 1, 2017, 00:00

  • Improper Medication Use By The Aged Population In Bahria Town, Lahore, Punjab, Pakistan

    Oct 1, 2017, 00:00

  • Assessing the Burden of Chronic Heart Failure on Patients in Colombia

    Oct 1, 2017, 00:00

  • Assessing The Robustness Of Direct Meta-Analysis In The Presence Of Heterogeneity

    Oct 1, 2017, 00:00

  • Overall Survival (OS) Versus Progression-Free Survival (PFS)- Is There A Rational For Replacing One Outcome For The Other?

    Oct 1, 2017, 00:00

  • Value Based Healthcare In Orthopaedic Surgery- An Evaluation Based On The Economist Intelligence Unit Global Assessment Framework

    Oct 1, 2017, 00:00

  • Quality of Life Among Patients with Diabetes Mellitus at King Abdulaziz University Hospital in Saudi Arabia

    Oct 1, 2017, 00:00

  • The Impact of Disability on Activities of Daily Living, Productivity and Independency in Patients with Multiple Sclerosis- Findings from a 2016 Study in Europe and the United States

    Oct 1, 2017, 00:00

  • Impact Of Time To Reimbursement Of Drug Treatments For Non-Small Cell Lung On Patient Outcomes In Europe And Latin America

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Aspects of Various Strategies of Vessel Sealing and Reduction of Postoperative Complications of Inguinal Lymph Nodes Dissection in Patients with Gynecologic Cancers

    Oct 1, 2017, 00:00

  • Therapeutic Strategies Utilization and Resources Consumption in Patients Treated for Psoriatic Arthritis in Italy

    Oct 1, 2017, 00:00

  • Idiopathic Pulmonary Fibrosis- Where The Functional Health Deterioration and The High Economic Impact Are Inseparable. Challenges In A Latin American Country

    Oct 1, 2017, 00:00

  • Benefit-Risk And Medical Costs of Rivaroxaban 20mg Versus Vitamin K Antagonists From A French Nationwide Cohort of 220,000 Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Impacto Orçamentário Da Incorporação De Tofacitinibe No Sistema Único De Saúde

    Oct 1, 2017, 00:00

  • The Impact of Vaccination And Patient Characteristics on Influenza Vaccination Uptake

    Oct 1, 2017, 00:00

  • Economic Evaluation of Dialysis Dependence Following Renal Replacement Therapy for Critically ILL Acute Kidney Injury Patients

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK

    Oct 1, 2017, 00:00

  • Does The Nice Diagnostics Assessment Programme Use An Empirical Icer Threshold?

    Oct 1, 2017, 00:00

  • Practicalities Of Using Real-World Evidence (RWE) In Comparative Effectiveness Research (CER)- Learnings From Imi-Getreal

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Dimethyl Fumarate Versus Teriflunomide for The Treatment of Multiple Sclerosis

    Oct 1, 2017, 00:00

  • Matching-Adjusted Indirect Comparison (MAIC)- Sensitivity Analyses And Graphical Diagnostics

    Oct 1, 2017, 00:00

  • Exploring Disinvestment Desicions In The NHS Via Health Economics

    Oct 1, 2017, 00:00

  • How Policy-Makers Should Understand Qualitative Evidence Regarding Public Opinion

    Oct 1, 2017, 00:00

  • Assessment of Healthcare Costs of Infants In Exclusive Breastfeeding Versus Mixed or Artificial Breastfeed

    Oct 1, 2017, 00:00

  • Economic Evaluation of 10% Intravenous Immunoglobulin In Treatment of Primary Immunodeficiencies In Adults In The Russian Federation

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Empagliflozin (Jardiance®) In Type-2 Diabetes Patients With High Cardiovascular Risk In The South African Setting- A Retrospective Claims Database Analysis

    Oct 1, 2017, 00:00

  • The Unique Characterisitcs Of Adoptive Immunotherapies For Health Economic Evaluations

    Oct 1, 2017, 00:00

  • Changes In Private Financing Of The Greek Health System During The Economic Crisis

    Oct 1, 2017, 00:00

  • The Risks In Translating Smartphone Strings For Medical Study Smartphones Apps Smartwatches

    Oct 1, 2017, 00:00

  • The Post-Traumatic Stress Disorder And Medication Adherence Encountered At Patients With Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Matching-Adjusted Indirect Comparison (MAIC) Of Crizotinib With Standard of Care In Progressed Nsclc ALK+ Patients Based On Real-World Evidence (RWE) And Clinical Trial Data In The Czech Republic

    Oct 1, 2017, 00:00

  • Evolución De La Calidad De Atención En Personas Con Diabetes Tipo 2 (DMT2) De Argentina- Resultados Del International Diabetes Management Practices Study (IDMPS)

    Oct 1, 2017, 00:00

  • Use of Biological Based Therapies and Assessment of Health Related Quality of Life Among Thalassaemia Patients

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Brazil

    Oct 1, 2017, 00:00

  • Sodium-Glucose Co-Transporter-2 (Sglt-2) Inhibitors And The Risk of Fractures of The Upper or Lower Limb In Patients With Type 2 Diabetes- A Nested-Case Control Study

    Oct 1, 2017, 00:00

  • The Incidence Of Liver Complications In Israel

    Oct 1, 2017, 00:00

  • Cost Per Life Saved Of Adjunctive Igm-Enriched Immunoglobulin Treatment Of Sepsis In Germany

    Oct 1, 2017, 00:00

  • Assessing Health-Related Quality Of Life In Patients With Psoriasis Compared With The Portuguese Population

    Oct 1, 2017, 00:00

  • The Humanistic Burden of Microsatellite Instability-High (MSI-H) Colorectal Cancer (CRC) and Metastatic CRC (MCRC) Patients Treated with Subsequent Line Therapy- A Systematic Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer in Portugal

    Oct 1, 2017, 00:00

  • Ethical Requirements for the Conduct of Drug Utilization Studies in Latin America- A Cross-Sectional Survey

    Oct 1, 2017, 00:00

  • Public Perceptions, Attitudes And Willingness To Pay Towards A Medical Device For Detecting Foot Ulceration In People with Diabetes

    Oct 1, 2017, 00:00

  • Health Effects of Micronutrient Fortified Milk and Cereal Food for Children and Adolescents- A Systematic Review

    Oct 1, 2017, 00:00

  • Estimating the Financial Impact of Introducing Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) From the Perspective of Public Payer of São Paulo (Sp) – Brazil

    Oct 1, 2017, 00:00

  • A Review Of Methodology And Response To Iqwig Report “Treatment Of Haemophilia Patients”

    Oct 1, 2017, 00:00

  • The Practice of Decision-Making of Public Health Authorities In Poland on Reimbursement of Orphan Drugs

    Oct 1, 2017, 00:00

  • Using Ticagrelor to Enhance Outcomes for Acute Coronary Syndromes (ACS) Patients at Low Middle Income Countries

    Oct 1, 2017, 00:00

  • Clinical Trial Simulations Based on A Meta-Analysis of Studies In Patients With Locally Advanced and/or Metastatic Adenocarcinoma Pancreatic Cancer Receiving Gemcitabine (GEM) Alone or In Combination

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Argentina

    Oct 1, 2017, 00:00

  • Does The Reimbursement Of In-Patient Hospital Services Adequately Cover Novel Antibiotic Pharmaceuticals In The U.S., EU4 And England? Discussion Of Current Mechanisms In Place

    Oct 1, 2017, 00:00

  • A Systematic Review Of Predictive Models In Acute Heart Failure

    Oct 1, 2017, 00:00

  • Modelización Económica Del Ajuste Por Riesgo Del Gasto Sanitario Per Cápita Segun Morbilidad En La Comunidad Valenciana, España

    Oct 1, 2017, 00:00

  • Prioritizing Patient-Relevant Attributes of HIV Medications- A Mixed Methods Approach

    Oct 1, 2017, 00:00

  • Preferences for Survival in Non-Small Cell Lung Cancer- Swinging for Home Runs or Base Hits?

    Oct 1, 2017, 00:00

  • Which PSM Method To Use? Association Between Chosen Ppropensity Score Method And Outcomes Of Retrospective Real-World Treatment Comparisions- Evaluation Of 18 Different PSM Methods

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Long-Acting Parenteral Antipsychotic Drug Flufenazine In The Treatment of Schizophrenia In Russia- A Hospital Perspective

    Oct 1, 2017, 00:00

  • German Situation of Treatment with Biological Agents Among Patients with Psoriasis Based on A Claims Data Analysis

    Oct 1, 2017, 00:00

  • An Algorithm To Quantttatively Estimate Extrapolated Lifetime Survival Curves For Economic Evaluation (EE) of Cancer Treatments When Only Aggregated Patient Data Are Available; With Application To Metastatic Pancreatic Cancer

    Oct 1, 2017, 00:00

  • Plan De Atencion De Cuidados Paliativos Y Cuidados De Fin De Vida

    Oct 1, 2017, 00:00

  • Assessment of Nurse's Knowledge, Attitude and Practice Regarding Hepatitis-B Infection in Tertiary Care Public Hospital in Quetta Pakistan

    Oct 1, 2017, 00:00

  • Does Using Factor Analysis to Select Covariates in Mapping Algorithms Improve Predictive Accuracy? A Case of Mapping the Core 23-Item Women’s Health Questionnaire Onto the EQ-5D-5L and SF-6D

    Oct 1, 2017, 00:00

  • Labour Productivity Losses Associated with Breast Cancer- An Analysis Along A Decade in Spain

    Oct 1, 2017, 00:00

  • Comparative Efficacy and Safety of Interventions For Preventing Chemotherapy Induced Oral Mucositis In Adult Cancer Patients- A Systematic Review And Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Maternal Screening And Treatment For Group B Streptococcus (GBS) Are Associated With Non-Adherence To Guidelines, False-Negative Results And High Management Costs In The United Kingdom, Italy, France, Spain And Germany

    Oct 1, 2017, 00:00

  • Epidemiology Of Healthcare Registered As Sexual Abuse Against Women In Brazil

    Oct 1, 2017, 00:00

  • Evidence Syntheses On The Economic Value Of Hospital Antimicrobial Stewardship Programs [ASPS] – A Call To Action

    Oct 1, 2017, 00:00

  • Gamification, What Is It and How Can It Be Used In Health Outcomes Research?

    Oct 1, 2017, 00:00

  • Application Of Multi-Criteria Decision Analysis (MCDA) To Determine The Value Of Treatments For The Moderate To Severe Plaque Psoriasis In Spain

    Oct 1, 2017, 00:00

  • Predictive Analysis for Identifying Patient Characteristics Associated with Primary Medication Nonadherence for Lipid Lowering Therapies

    Oct 1, 2017, 00:00

  • Medical Transportation Costs In Fran Which Source To Estimate Them In Health-Economic Analysis?

    Oct 1, 2017, 00:00

  • The Case For Combination Therapy - Clinical And Economic Value Differentiation Strategies In Saturated Oncology Therapy Areas

    Oct 1, 2017, 00:00

  • Market Share And Switching Dynamics Between Etanercept And Its Biosimilar Product In Sweden And Germany- A Real-World Preliminary Analysis

    Oct 1, 2017, 00:00

  • Budget Impact of Alectinib in The Treatment of Naïve Anaplastic Lymphoma Kinase-Positive (ALK+) Advanced Non-Small Cell Lung Cancer (NSCLC) in Greece

    Oct 1, 2017, 00:00

  • Estimation of the Budget Saving Potential Due to the Introduction of an Etanercept Biosimilar (SB4) for the Treatment of Approved Adult Etanercept Indications in Portugal

    Oct 1, 2017, 00:00

  • Analgesics Prescription Pattern In A Specialist Teaching Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Is the Disconnect Between European Member State Controlled Compassionate Use Programs and the Centralised EMA Process Creating an Early Access Lottery for Patients?

    Oct 1, 2017, 00:00

  • Estimating The Lifetime Total Economic Costs Of Respiratory Disease In Beef And Dairy Calves In The UK

    Oct 1, 2017, 00:00

  • Factors Related To Outpatient Antibiotic Drug Consumption In Turkey

    Oct 1, 2017, 00:00

  • Adjusting for Selection Bias in Evaluating Two-Dose Human Papillomavirus Vaccine Coverage Among Adolescents in the United States

    Oct 1, 2017, 00:00

  • Systematic Review of Cohort-Level Economic Models for Antipsychotics In Schizophrenia

    Oct 1, 2017, 00:00

  • Economic Analysis of Alk Related Companion Diagnosis Methods Before the Targeted Therapy for Non-Small Cell Lung Cancer

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact At Health Related Quality Of Life At Patients Diagnosed With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • Burden of Healthcare Costs for Merkel Cell Carcinoma Management in Spain

    Oct 1, 2017, 00:00

  • Costo Y Consumo De Recursos De Pacientes Posterior A Enfermedad Cerebrovascular En Colombia

    Oct 1, 2017, 00:00

  • Attitude Of Pakistani Pharmacy Students Towards Postgraduate Education

    Oct 1, 2017, 00:00

  • The Development And Use Of A Preliminary Conceptual Model Of Inflammatory Bowel Disease (IBD) To Facilitate Patient Reported Outcome (PRO) Instrument Selection For A UK Real-World Evidence Study

    Oct 1, 2017, 00:00

  • Trend In Hospital Cases of Acquired Hemophilia A (AHA) 2010-2015 In Germany

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Pirfenidone Versus Nintedanib on The Treatment of Idiopathic Pulmonary Fibrosis

    Oct 1, 2017, 00:00

  • Access Gap To Innovative Treatments In Romania

    Oct 1, 2017, 00:00

  • Factors Associated with Multi-Drug Resistant Tuberculosis Incidence In Ghana- A 1-2 Unmatched Case Control Study, 2017

    Oct 1, 2017, 00:00

  • Characterization of Low Density Lipoprotein (LDL) Levels in Patients Diagnosed with Arterial Hypertension and Diabetes in Colombian Population in the Year 2016

    Oct 1, 2017, 00:00

  • Prevalence of and Barriers to Medication Adherence Among Patients with Uncontrolled Diabetes Mellitus in Primary Healthcare Centers in Qatar- A Quantitative Analysis

    Oct 1, 2017, 00:00

  • A Network Meta-Analysis to Evaluate The Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis

    Oct 1, 2017, 00:00

  • The Study on Mechanism of Nf-Κb Signal Molecule In Kashin-Beck Disease

    Oct 1, 2017, 00:00

  • A Network Meta-Analysis to Compare the Efficacy and Safety Of Antipsychotics As Maintenance Treatment For Patients With Schizophrenia

    Oct 1, 2017, 00:00

  • GDP And Population Size – Important Determinants of Schizophrenia-Related Healthcare Costs In The European Countries

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Assessment of Sucroferric Oxyhydroxide Vs Sevelamer Carbonate In Patients With Chronic Kidney Disease In Belgium and The Netherlands

    Oct 1, 2017, 00:00

  • Toric Intraocular Lenses for the Correction of Pre-Existing Corneal Astigmatism During Cataract Surgery- A Systematic Review of the Literature

    Oct 1, 2017, 00:00

  • Analysis Of Financial Status And The Investment Strategy Of National Hospital Organization (NHO) In Japan From 2004 TO 2015

    Oct 1, 2017, 00:00

  • Health Related Quality of Life in Cancer Immunotherapy- Previously Treated, Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

    Oct 1, 2017, 00:00

  • Patient-Reported Outcomes of Opioid-Induced Constipation as Identified Through Social Media

    Oct 1, 2017, 00:00

  • Estimating The Cost of Diabetes-Related Cardiovascular Complications In Selected Central And Eastern European Countries

    Oct 1, 2017, 00:00

  • Valor Monetario De Las Muertes De Motociclistas En Colombia

    Oct 1, 2017, 00:00

  • A Discrete Choice Experiment To Elicit Diabetes Treatment Preferences Among Adolescents With Type 1 In Western Australia

    Oct 1, 2017, 00:00

  • Comparison Of Women’s Health Care In Germany, Austria And Switzerland Regarding Surgical Therapy Options For Patients With Abnormal Uterine Bleeding

    Oct 1, 2017, 00:00

  • E-Health Funding In Europe

    Oct 1, 2017, 00:00

  • Evaluation Of Structured Educational Intervention To Community Pharmacists Towards Adverse Drug Reaction Reporting And Monitoring In South Indian District

    Oct 1, 2017, 00:00

  • Comparing ITC Results From Lenvatinib Plus Everolimus For Second-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- Crossover Versus No Crossover

    Oct 1, 2017, 00:00

  • Characteristics Of Patients Treated With Cetuximab-Based Extreme Regimen In 1ST Line R/M Scchn Cancer In Real Life Setting, In France In 2012-2015

    Oct 1, 2017, 00:00

  • Healthcare Interventions For Improving Quality Use Of Antibiotics In The Hospital Setting- A Systematic Review

    Oct 1, 2017, 00:00

  • Pathways to Dementia Diagnosis and Post-Diagnostic Support- the Bavarian Dementia Survey

    Oct 1, 2017, 00:00

  • Quality Of Reporting And Analysis Of Trial-Based Cost Efectiveness Evaluations In Obstetrics And Gynaecology; A Systematic Review

    Oct 1, 2017, 00:00

  • Mapping from SF-36 Trial Data To EQ-5D Utilities in Advanced Basal Cell Carcinoma

    Oct 1, 2017, 00:00

  • A Multicenter, Observational Study To Evaluate Comorbidities In Patients Above 50 Years of Age – Aging Positive- A Comparison of Medical Charts And Patients Self-Reported Data

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Improves Itching And Health-Related Quality (HRQOL) of Life In Psoriasis Patients In Latin America

    Oct 1, 2017, 00:00

  • Paying For Gene Therapies- Approaching A Sustainable Solution

    Oct 1, 2017, 00:00

  • COMPARISON OF VARIOUS SEVERITY ASSESSMENT SCORING SYSTEMS IN PATIENTS WITH SEPSIS

    Oct 1, 2017, 00:00

  • Survey Of Nurses’ Knowledge About Surgical Wound Care And Its Complications And The Knowledge Of Wound Dressings

    Oct 1, 2017, 00:00

  • Costs Of Ownership Of Ready-To-Administer Pre-Filled Sterilized Syringes In A Dutch Hospital; A Cost Minimization Analysis

    Oct 1, 2017, 00:00

  • Biosimilar Discounts are Not Similar- A Comparison of The Prices and Discounts of Anti-Tnf Biosimilars Between Canada and Europe

    Oct 1, 2017, 00:00

  • Patient Input into Value Assessment of Respiratory Medicines- Lessons Learned from Value Frameworks in other Disease Areas

    Oct 1, 2017, 00:00

  • Value Added Medicines- Adjustements of HTA Decision Frameworks To Capture Their Full Value

    Oct 1, 2017, 00:00

  • Opportunity Cost Of Non-Rigorous Or Non-Transferable Research- Implications For Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Chidamide Versus Chemotherapy on The Treatment of Peripheral T - Cell Lymphoma Patients In China

    Oct 1, 2017, 00:00

  • PRM178Evaluation And Validation Of The Proact Measures For Cancer Patients And Informal Caregivers

    Oct 1, 2017, 00:00

  • Comparative Analysis of The Development of The Bulgarian and The Romanian HTA System

    Oct 1, 2017, 00:00

  • Characteristics And Treatment Patterns In Patients Treated For Relapsed Refractory Multiple Myeloma Over 3 Years- Premiere Study

    Oct 1, 2017, 00:00

  • Characterisitcs of Patients Receiving Leflunomide, Methotrexate or Leflunomide Plus Methotrexate for the Treatment of Rheumatoid Arthritis in a Real-Life Setting in Colombia

    Oct 1, 2017, 00:00

  • Sentiment Analysis of Social Media Posts from Renal Cell Carcinoma (RCC) Patients

    Oct 1, 2017, 00:00

  • Costs of Chemotherapy-Induced Adverse Events in Head and Neck Cancer in France

    Oct 1, 2017, 00:00

  • Predicting Outcomes From Multiple Uncontrolled Historical Studies of Treatment of Physician’s Choi Progression-Free Survival And Overall Survival In Untreated Metastatic Merkel Cell Carcinoma

    Oct 1, 2017, 00:00

  • Patterns of Biological Therapy Use in Patients with Rheumatoid Artrhitis in a Real-Life Setting in Colombia

    Oct 1, 2017, 00:00

  • Treatment Patterns of Chronic Heart Failure (CHF) In Mexico

    Oct 1, 2017, 00:00

  • Severe Depression as a Risk Factor for Osteoporosis- A Real World Data Study Conducted in Italy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of A Randomized Trial Of An Mhealth Intervention To Improve Cardiometabolic Profile In Prehypertensive Subjects From Low-Resource Urban Settings In Latin America

    Oct 1, 2017, 00:00

  • Granulocyte-Colony Stimulating Factor (G-CSF)- Potential Financial Savings For German Hospitals

    Oct 1, 2017, 00:00

  • Crises Econômicas E Seus Impactos No Sistema De Saúde Do Brasil

    Oct 1, 2017, 00:00

  • Does Community-Based Health Insurance Reduce Child Stunting? Evidence From Rural Uganda

    Oct 1, 2017, 00:00

  • Patterns of Biologics Use In Ankylosing Spondylitis And Psoriatic Arthritis Patients In Korea

    Oct 1, 2017, 00:00

  • Revisão Sistemática Das Diretrizes De Análise De Impacto Orçamentário

    Oct 1, 2017, 00:00

  • A Qualitative Exploration of Reasons for (NON-) Adherence to Oral Anticoagulant Therapy in Patients with Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Clinical And Economic Value Of Device-Based Detection Of Atrial Fibrillation In Patients With Cryptogenic Stroke

    Oct 1, 2017, 00:00

  • Benefit-Risk And Medical Costs of Rivaroxaban 15mg Versus Vitamin K Antagonists From A French Nationwide Cohort of 220,000 Patients With Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • The Global Burden Of Gastric (GC) And Gastroesophageal Junction (GEJC) Cancers

    Oct 1, 2017, 00:00

  • Análisis De Impacto Presupuestario Comparando 2 Métodos De Screening De Cáncer De Cuello Uterino (CCU) EN EL Sector De Obras Sociales De Argentina

    Oct 1, 2017, 00:00

  • Indicative Budget Impact Of Posaconazole Versus Fluconazole In Invasive Fungal Infection Prophylaxis In Adult Patients With AML/MDS

    Oct 1, 2017, 00:00

  • Costo-Efectividad De La Deteccion De Adn De Virus De Papiloma Humano De Alto Riesgo Para Tamizaje De Cancer De Cuello Uterino En Ecuador

    Oct 1, 2017, 00:00

  • The Importance of Perspective When Evaluating The Economic Value of Vocational Rehabilitation

    Oct 1, 2017, 00:00

  • Worldwide Research Productivity on Biosimilars- A Bibliometric Analysis

    Oct 1, 2017, 00:00

  • Micro Economic Analysis Of The COPD Exacerbations And Hospitalizations Burden On The Health Care System In Bulgaria

    Oct 1, 2017, 00:00

  • Perceived Service Quality And Patient Satisfaction At Pharmacy Department In Yogyakarta, Indonesia

    Oct 1, 2017, 00:00

  • Work Productivity And Impairment Among Patients With Light Chain Amyloidosis

    Oct 1, 2017, 00:00

  • Non-Interventional Real-World European Study Quantifying The Burden Of Central Nervous System (CNS) Metastases On Healthcare Resource Use (HRU) In Patients With Metastatic Non-Small-Cell Lung Cancer (MNSCLC) – Results From An Interim Analys ...

    Oct 1, 2017, 00:00

  • Accelerated Uptake Of Innovative Health Technologies- A Literature Review

    Oct 1, 2017, 00:00

  • Knowledge And Attitudes Identifying Victims Of Human Trafficking In The US- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Influenza-Related Attitudes of Healthcare Workers At Institutions for Acute and Chronic Diseases

    Oct 1, 2017, 00:00

  • No Price Negotiation – The Strategy Of Aok Bavaria Tested – For Inpatient Hemophilia Care

    Oct 1, 2017, 00:00

  • Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Right Hemicolectomy- A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Spanish Patient’s Perspective and Preferences for Telemedicine Resources in Type 2 Diabetes Management

    Oct 1, 2017, 00:00

  • Potential Medication Triggers Of Deteriorated Renal Function Among Patients With Type 2 Diabetes- Using Real World Data

    Oct 1, 2017, 00:00

  • Comparison Ofsecukinumab Vs Adalimumab in a Cost Per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthrisis at 48 Weeks from a Moroccan Perspective

    Oct 1, 2017, 00:00

  • Cost –Utility Analysis of Two Budesonide Inhalers For Treatment of Asthma In Children In Russian Federation

    Oct 1, 2017, 00:00

  • Cost of Non-Union In Patients with Lower Leg Fractures

    Oct 1, 2017, 00:00

  • Finding Undiagnosed Patients With Hepatitis C Virus- An Application Of State-Of-The-Art Machine Learning Methods

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Interventions That Have Not Shown Clinical Effectiveness

    Oct 1, 2017, 00:00

  • Inappropriate Prescribing of Antithrombotics Causes Poor Discharge Outcomes In Hospitalized Elderly Patients Using Stopp/Start Criteria 2015, A Retrospective Cohort Study

    Oct 1, 2017, 00:00

  • Boceprevir and Telaprevir Effectiveness and Safety in A Brazilian Cohort of Chronic Hepatitis C Genotype 1 Patients- A Multicentric Longitudinal Study

    Oct 1, 2017, 00:00

  • Moving Pro Measures from the Promise to Impact in Oncology Clinical Practi Results from a Systematic Literature Review

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns in Metastatic and/or Unresectable Gastric Cancer in Patients From Argentina

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Liver Transplantation Compared To Chemotherapy for Non-Resectable Liver-Only Metastases After Colorectal Cancer (MCRC)

    Oct 1, 2017, 00:00

  • Rheumatoid Arthritis Patients’ Perspectives On The Value Of Patient Preferences In Regulatory Decision-Making During Drug Development- A Qualitative Study

    Oct 1, 2017, 00:00

  • Factors Associated with the Prevalence of Time in Front of Tv Between Brazilian Schoolers (2012 and 2015)

    Oct 1, 2017, 00:00

  • Using Diabetes Self-Management Questionnaire (DSMQ) to Assess Diabetes Self-Care Activities for Diabetes Patients in King Fahad University Hospital - Saudi Arabia

    Oct 1, 2017, 00:00

  • Accurate Representation Of Patients’ Opinions For Decision-Making- Are Online Health Communities Good Candidates?

    Oct 1, 2017, 00:00

  • Prescribing Pattern Of Antibiotics For Acinetobacter Infection In A Tertiary Care Hospital

    Oct 1, 2017, 00:00

  • PCN3 Pattern of Chemotherapy Related Adverse Effects Among Adult Cancer Patients Treated At Gondar University Referral Hospital, Ethiopia- A Cross Sectional Study

    Oct 1, 2017, 00:00

  • Economic Impact Of Severe Asthma In Spain- Observational Longitudinal Multicenter Study

    Oct 1, 2017, 00:00

  • Prediction Of Costs On Antiretroviral Therapy In The Republic Of Belarus

    Oct 1, 2017, 00:00

  • Preferences for Route of Administration, Frequency and Location - A Time-Trade-Off Study in the Italian General Population

    Oct 1, 2017, 00:00

  • Spontaneous Abortion is Associated with an Increased Risk of Developing Psychiatric Diseases

    Oct 1, 2017, 00:00

  • Classification of Causes of Hospitalization For Heart Failure Patients In Cost-Effectiveness and Cost-Utility Evaluations of Pharmacotherapeutic, Surgical, and Managed-Care Interventions- Systematic Review

    Oct 1, 2017, 00:00

  • Patient Perception With Respect To The Overall Experience To A Patient-Friendly Equipment Design And The Impact Of Patient-Assisted Compression Feature During A Mammography Exam

    Oct 1, 2017, 00:00

  • Real-World Health Care Resource Utilization and Related Costs Among Patients Who Received At Least Two Lines of Treatment for Advanced Nsclc in England, The Netherlands, and Sweden

    Oct 1, 2017, 00:00

  • Early Modelling of The Cost-Effectiveness of Stratified Medicine In COPD

    Oct 1, 2017, 00:00

  • Economic Evaluation of Trifluridine and Tipiracil Hydrochloride in The Treatment of Metastatic Colorectal Cancer in Greece

    Oct 1, 2017, 00:00

  • Effect of Gastrointestinal Adverse Events on Treatment Satisfaction in Semaglutide Treatment of Type 2 Diabetes

    Oct 1, 2017, 00:00

  • Patients’ Preferences Related to Treatments for Endometriosis-Related Pain- Results of a Discrete Choice Experiment in the UK

    Oct 1, 2017, 00:00

  • Custo Efetividade Do Uso Dos Inibidores De Protease No Tratamento Da Hepatite C Crônica- Comparação Entre O Uso Universal E O Uso Restrito Na Fibrose Avançada

    Oct 1, 2017, 00:00

  • Estimating The Prevalece of Depression In Patients With Rheumatoid Arthritis In Korea Using National Health Insurance Claims Data

    Oct 1, 2017, 00:00

  • Management And Cost Analysis Of Cancer Patients Treated With G-CSF- A Cohort Study Based On The French National Healthcare Insurance Database (Echantillon Généraliste Des Bénéficiaires)

    Oct 1, 2017, 00:00

  • Managed Entry Agreements (MEA)- Analysis Of The Current Situation In Middle East And North Africa

    Oct 1, 2017, 00:00

  • 3-Steps Stragety for Patients Early Access to an Unauthorized Medication / Device Project Design (Based on 23 Projects Analyses Including EAP, CUP, NPP, IND, ATU)

    Oct 1, 2017, 00:00

  • Real World Data Analysis Of A Patient-Tailored, Post-Discharge Support Program For Patients Undergoing An Ostomy Surgery In Lowering Readmissions And Emergency Room Visits

    Oct 1, 2017, 00:00

  • Non-Opioid Analgesic Reimbursement In Europe- A Comparative Study

    Oct 1, 2017, 00:00

  • Impacto Económico De La Hipoglucemia En Colombia

    Oct 1, 2017, 00:00

  • Resource use and Health-Care Costs of Chronic Lymphocytic Leukemia in Slovakia

    Oct 1, 2017, 00:00

  • Aedes Aegypt- Economic Impact of Prevention Versus Palliation of Diseases Caused By The Mosquito

    Oct 1, 2017, 00:00

  • Pharmaceutical Assistance Public Funding In A Brazilian City And Its Implications For The Universal Access To Essential Medicines

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Empagliflozin For The Treatment of Patients With Type 2 Diabetes Mellitus At Increased Cardiovascular Risk In Greece

    Oct 1, 2017, 00:00

  • Cost Analysis of Pre-Dialysis- A Model in the Brazilian context

    Oct 1, 2017, 00:00

  • Quality of Life in Patients with Kidney Transplantation in Czech Republic

    Oct 1, 2017, 00:00

  • Burnout Syndrome among Healthcare Professionals working in Gondar University Hospital, Northwest Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • The First EQ-5D-5L Value Set In Central And Eastern Europe

    Oct 1, 2017, 00:00

  • Healthcare Costs Of Patients With Acute And Chronic Graft-Versus-Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation In Belgium- A Retrospective Data Collection And Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Alemtuzumab In The Treatment of Relapsing Forms of Multiple Sclerosis In The United States and Societal Spillover Effects

    Oct 1, 2017, 00:00

  • Health Care Resource Use (HCRU) Due To Bleeding Related Episodes (BRE) In Patients With Immune Thrombocytopenic Purpura (ITP) Receiving Eltrombopag (EPAG), Romiplostim (ROMI), Or Rituximab (RITUX)- Real World Evidence (RWE) From 27 US Insti ...

    Oct 1, 2017, 00:00

  • Idiopathic Pulmonary Fibrosis- A Cost Of Illness Analysis In Greece

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Daratumumab in Heavily Pre-Treated Multiple Myeloma Patients for The Italian Healthcare System

    Oct 1, 2017, 00:00

  • Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness- Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making

    Sep 1, 2017, 00:00

  • ERRATUM

    Sep 1, 2017, 00:00

  • Editorial Board

    Sep 1, 2017, 00:00

  • Market Exclusivity Time for Top Selling Originator Drugs in Canada- A Cohort Study

    Sep 1, 2017, 00:00

  • Estimating the Effect and Economic Impact of Absenteeism, Presenteeism, and Work Environment–Related Problems on Reductions in Productivity from a Managerial Perspective

    Sep 1, 2017, 00:00

  • Making Real-World Evidence More Useful for Decision Making

    Sep 1, 2017, 00:00

  • Evaluation of a Stratified National Breast Screening Program in the United Kingdom- An Early Model-Based Cost-Effectiveness Analysis

    Sep 1, 2017, 00:00

  • A Systematic Review of the Economic Evidence for Home Support Interventions in Dementia

    Sep 1, 2017, 00:00

  • Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists

    Sep 1, 2017, 00:00

  • Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

    Sep 1, 2017, 00:00

  • Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb- Examining the Association of Severity and Treatment Regimens with Costs and Annual Bleed Rates

    Sep 1, 2017, 00:00

  • An Experience-Based Value Set for the EQ-5D-5L in Germany

    Sep 1, 2017, 00:00

  • Cost Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal

    Sep 1, 2017, 00:00

  • Copyright/Subscription

    Sep 1, 2017, 00:00

  • Cost-Utility of Partially Implantable Active Middle Ear Implants for Sensorineural Hearing Loss- A Decision Analysis

    Sep 1, 2017, 00:00

  • Economic Evaluations of Pathology Tests, 2010-2015- A Scoping Review

    Sep 1, 2017, 00:00

  • Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis

    Sep 1, 2017, 00:00

  • A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data

    Sep 1, 2017, 00:00

  • Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration

    Sep 1, 2017, 00:00

  • Do Robotic Surgical Systems Improve Profit Margins? A Cross-Sectional Analysis of California Hospitals

    Sep 1, 2017, 00:00
  • «
  • 71
  • 72 (current)
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »